In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Remodulin Drug Master File in Korea (Remodulin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Remodulin. The MFDS reviews the Remodulin KDMF as part of the drug registration process and uses the information provided in the Remodulin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Remodulin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Remodulin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Remodulin suppliers with KDMF on PharmaCompass.